Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Catalyst Pharmaceutical (CPRX)

Add to Watchlists
Create an Alert
2.08 -0.04  -1.89% NASDAQ Apr 23, 8:00PM BATS Real time Currency in USD
View Full Chart
CPRX Price Chart
View All Events

CPRX Events

Date Type Description
Mar 19 Earnings Catalyst Pharmaceutical Partners, Inc. Q4 2013 Earning Result. Estimate: -0.07.
Nov 14 Earnings Catalyst Pharmaceutical Partners Announces Third Quarter 2013 Financial Results. Estimate: -0.07.
Aug 15 Earnings Catalyst Pharmaceutical Partners Announces Second Quarter 2013 Financial Results. Estimate: -0.07.
May 30 Misc AGM Event for Catalyst Pharmaceutical Partners, Inc
May 16 Earnings Catalyst Pharmaceutical Partners Reports First Quarter 2013 Financial Results. Estimate: -0.02.
View All Performance Charts

CPRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Catalyst Pharmaceutical is up 126.1% over the last year vs S&P 500 Total Return up 21.33%, Biomarin Pharmaceutical down 8.97%, and Takeda Pharmaceutical down 16.33%.

Get Quote for

Portfolio Strategies Featuring CPRX

Did Catalyst Pharmaceutical make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CPRX Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: Florida
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Catalyst Pharmaceutical Partners, Inc. is a biopharmaceutical Company. It develops and commercializes prescription drugs targeting diseases of the central nervous system with a focus on the treatment of drug addiction and epilepsy.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CPRX 2.08 -0.04 -1.89% 112.60M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.